Effect of surgical therapy for patients with cranio-maxillo-facial fibrous dysplasia on visual acuity: a systematic review

doi:10.19438/j.cjoms.2021.01.013

Abstract

Abstract: PURPOSE: To investigate the clinical effect and safety of surgical operation for patients who suffered from cranio-maxillo-facial fibrous dysplasia (CFD) on the aspect of visual acuity. METHODS: PubMed, Web of Science, Cochrane Library, Cochrane Clinical Trials Registration Center, CNKI, Wanfang database and VIP database were searched respectively and successively by computer up to now. All the patients who suffered from CFD were included, and the ones without visual impairment were defined as the experimental group, the other ones who got visual damage were defined as the control group. The total number of patients with visual impairment because of therapeutic surgery was extracted, and the data were processed in the way of meta-analysis. RESULTS: Fixed effect model was used for meta-analysis because there was good homogeneity between the studies (Chi²=8.63, df=9, P=0.47, I²=0%). Patients who had not visual impairment accepted surgery for their CFD as treatments and surgery did not increase the incidence of visual impairment[OR=0.39,95%CI(0.18-0.86),P=0.02]. There was no publication bias among the studies as well. CONCLUSIONS: Applying surgical operation for the treatment of CFD may not increase the possibility of visual impairment.

Key words: Cranio-maxillo-facial fibrous dysplasia, Surgical treatment, Optic nerve

CLC Number:

R782.2

LUO Dan, LI Chen-xi, GONG Zhong-cheng. Effect of surgical therapy for patients with cranio-maxillo-facial fibrous dysplasia on visual acuity: a systematic review[J]. China Journal of Oral and Maxillofacial Surgery, 2021, 19(1): 64-69.

References

[1] Boyce AM, Collins MT.Fibrous dysplasia/McCune-Albright syndrome: a rare, mosaic disease of Galphas activation[J]. Endocr Rev, 2020, 41(2): 345-370.
[2] Couturier A, Aumaitre O, Gilain L, et al.Craniofacial fibrous dysplasia: a 10-case series[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2017, 134(4): 229-235.
[3] Lee JS, FitzGibbon E, Butman JA, et al. Normal vision despite narrowing of the optic canal in fibrous dysplasia[J]. N Engl J Med, 2002, 47(21): 1670-1676.
[4] Burke AB, Boyce AM, Collins MT.Fibrous dysplasia: management of the optic canal[J]. Plast Reconstr Surg, 2016, 137(6):e1060-e1061.
[5] Amit M, Collins MT, FitzGibbon EJ, et al. Surgery versus watchful waiting in patients with craniofacial fibrous dysplasia: a meta-analysis[J]. PLoS One, 2011, 6(9): e25179.
[6] Yao Y, Liu Y, Wang L, et al.Clinical characteristics and management of growth hormone excess in patients with McCune-Albright syndrome[J]. Eur J Endocrinol, 2017, 176(3): 295-303.
[7] Shamir RR, Friedman Y, Joskowicz L, et al.Comparison of snellen and early treatment diabetic retinopathy study charts using a computer simulation[J]. Int J Ophthalmol, 2016, 9(1):119-123.
[8] 姜陶然, 曹德君, 俞哲元, 等. 颅面部骨纤维异常增生症28例临床分析[J]. 组织工程与重建外科杂志, 2013, 9(2): 106-108.
[9] Ooi EH, Glicksman JT, Vescan AD, et al.An alternative management approach to paranasal sinus fibro-osseous lesions[J]. Int Forum Allergy Rhinol, 2011, 1(1): 55-63.
[10] Tabrizi R, Ozkan BT.Craniofacial fibrous dysplasia of orbit[J]. J Craniofac Surg, 2008, 19(6): 1532-1537.
[11] Panda NK, Parida PK, Sharma R, et al.A clinicoradiologic analysis of symptomatic craniofacial fibro-osseous lesions[J]. Otolaryngol Head Neck Surg, 2007, 136(6): 928-933.
[12] Tan YC, Yu CC, Chang CN, et al.Optic nerve compression in craniofacial fibrous dysplasia: the role and indications for decompression[J]. Plast Reconstr Surg, 2007, 120(7): 1957-1962.
[13] 邱锷, 张天明, 刘浩成. 颅鼻眶部骨性病变的手术治疗[J]. 中国耳鼻咽喉头颈外科, 2006, 13(4): 261-264.
[14] Goisis M, Biglioli F, Guareschi M, et al.Fibrous dysplasia of the orbital region: current clinical perspectives in ophthalmology and cranio-maxillofacial surgery[J]. Ophthalmic Plast Reconstr Surg, 2006, 22(5): 383-387.
[15] Abe T, Satoh K, Wada A.Optic nerve decompression for orbitofrontal fibrous dysplasia: recent development of surgical technique and equipment[J]. Skull Base, 2006, 16(3): 145-155.
[16] Maher CO, Friedman JA, Meyer FB, et al.Surgical treatment of fibrous dysplasia of the skull in children[J]. Pediatr Neurosurg, 2002, 37(2): 87-92.
[17] Sharma RR, Mahapatra AK, Pawar SJ, et al.Symptomatic cranial fibrous dysplasias: clinico-radiological analysis in a series of eight operative cases with follow-up results[J]. J Clin Neurosci, 2002, 9(4): 381-390.
[18] Lustig LR, Holliday MJ, McCarthy EF, et al. Fibrous dysplasia involving the skull base and temporal bone[J]. Arch Otolaryngol Head Neck Surg, 2001, 127(10): 1239-1247.
[19] Thomas C, Mahapatra AK, Joy MJ, et al.Craniofacial surgery in Oman: a preliminary study of 10 cases[J]. J Craniofac Surg, 2001, 12(3): 247-252.
[20] Chen YR, Breidahl A, Chang CN.Optic nerve decompression in fibrous dysplasia: indications, efficacy, and safety[J]. Plast Reconstr Surg, 1997, 99(1): 22-30.
[21] Bibby K, McFadzean R. Fibrous dysplasia of the orbit[J]. Br J Ophthalmol, 1994, 78(4): 266-270.
[22] Edgerton MT, Persing JA, Jane JA.The surgical treatment of fibrous dysplasia. With emphasis on recent contributions from cranio-maxillo-facial surgery[J]. Ann Surg, 1985, 202(4): 459-479.
[23] Frisch CD, Carlson ML, Kahue CN, et al.Fibrous dysplasia of the temporal bone: a review of 66 cases[J]. Laryngoscope, 2015, 125(6): 1438-1443.
[24] Eolchiyan SA.Complex skull defects reconstruction with САD / САМ titanium and polyetheretherketone (PEEK) implants[J]. Zh Vopr Neirokhir Im N N Burdenko, 2014, 78(4): 3-13.
[25] Movassaghi K, Janecka I.Optic nerve decompression via mid-facial translocation approach[J]. Ann Plast Surg, 2005, 54(3): 331-335.
[26] Yang X, Guo Z, Mu X, et al.A lateral approach at the upper corner of the orbit in fronto-orbital fibrous dysplasia: less invasive and more effective approach for morphologic reconstruction and optic functional restoration[J]. J Craniofac Surg, 2009, 20(Suppl 2): 1831-1835.
[27] Le Shaw M, Kelley B, Camarata P, et al.Collateral damage: heat transfer as a possible mechanism of optic nerve injury during neurosurgical intervention[J]. Ophthal Plast Recons, 2012, 28(5): 328-330.
[28] Kabali TM, Moshy JR, Owibingire SS, et al.Craniofacial fibrous dysplasia associated with McCune-Albright syndrome: challenges in diagnosis and treatment: case reports[J]. BMC Oral Health, 2019, 19(1):180-187.
[29] Robinson C, Collins MT, Boyce AM.Fibrous Dysplasia/McCune-albright syndrome: clinical and translational perspectives[J]. Curr Osteoporos Rep, 2016, 14(5):178-186.
[30] Burke AB, Collins MT, Boyce AM.Fibrous dysplasia of bone: craniofacial and dental implications[J]. Oral Dis, 2017, 23(6): 697-708.
[31] Javaid MK, Boyce A, Appelman-Dijkstra N, et al.Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium[J]. Orphanet J Rare Dis, 2019, 14(1): 139-156.
[32] Hartley I, Zhadina M, Collins MT, et al.Fibrous dysplasia of bone and mccune-albright syndrome: a bench to bedside review[J]. Calcif Tissue Int, 2019, 104(5): 517-529.
[33] Li Z, Raynald, Wang Z, et al.Malignant transformation of craniofacial fibrous dysplasia: a systematic review of overall survival[J]. Neurosurg Rev, 2020, 43(3): 911-921.